1. Home
  2. DRCT vs CTXR Comparison

DRCT vs CTXR Comparison

Compare DRCT & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRCT
  • CTXR
  • Stock Information
  • Founded
  • DRCT 2018
  • CTXR 2007
  • Country
  • DRCT United States
  • CTXR United States
  • Employees
  • DRCT N/A
  • CTXR N/A
  • Industry
  • DRCT Computer Software: Programming Data Processing
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DRCT Technology
  • CTXR Health Care
  • Exchange
  • DRCT Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • DRCT 16.7M
  • CTXR 14.6M
  • IPO Year
  • DRCT 2022
  • CTXR N/A
  • Fundamental
  • Price
  • DRCT $0.51
  • CTXR $0.70
  • Analyst Decision
  • DRCT Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • DRCT 1
  • CTXR 3
  • Target Price
  • DRCT $6.00
  • CTXR $54.50
  • AVG Volume (30 Days)
  • DRCT 941.4K
  • CTXR 145.7K
  • Earning Date
  • DRCT 05-06-2025
  • CTXR 05-14-2025
  • Dividend Yield
  • DRCT N/A
  • CTXR N/A
  • EPS Growth
  • DRCT N/A
  • CTXR N/A
  • EPS
  • DRCT N/A
  • CTXR N/A
  • Revenue
  • DRCT $48,170,000.00
  • CTXR N/A
  • Revenue This Year
  • DRCT $53.01
  • CTXR N/A
  • Revenue Next Year
  • DRCT $11.11
  • CTXR N/A
  • P/E Ratio
  • DRCT N/A
  • CTXR N/A
  • Revenue Growth
  • DRCT N/A
  • CTXR N/A
  • 52 Week Low
  • DRCT $0.44
  • CTXR $0.65
  • 52 Week High
  • DRCT $6.59
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • DRCT 42.91
  • CTXR 39.87
  • Support Level
  • DRCT $0.44
  • CTXR $0.67
  • Resistance Level
  • DRCT $0.61
  • CTXR $0.75
  • Average True Range (ATR)
  • DRCT 0.06
  • CTXR 0.08
  • MACD
  • DRCT 0.00
  • CTXR 0.01
  • Stochastic Oscillator
  • DRCT 28.12
  • CTXR 10.06

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: